Upcoming events

    • April 13, 2024
    • 8:00 AM
    • April 13, 2025
    • 6:00 PM
    Register

    Welcome to 2024 CAN Program and thank you for sponsoring and exhibiting!

    This is Step 1. 

    To become a sponsor or exhibitor of 2024 CAN Program, please follow the steps below:

    1. Click the "Sponsor/Register" button at the right-corner and follow the step-by-step process to pay. The price will differ depends on level of sponsorship. Two payment methods:

    A. Pay by credit card.

    B. Pay by check. Click "invoice me" and then print out the invoice in your email. Mail the invoice together with the a check (payable to "CABS") to the following address: 268 Bush Street, #1888, San Francisco, CA 94104. U.S.A.

    2. You will receive an email to confirm your payment. High level sponsors will get free guest conference admission passes. Please go to Step 2 to register yourself and free guests for conference admission. 

    Please contact fundraising@cabsweb.org if you have any question!

    • September 07, 2024
    • 8:00 AM
    • September 07, 2025
    • 6:00 PM
    • South San Francisco Convention Center
    Registration is closed

    Welcome to 2024 BioPacific Conference  and thank you for sponsoring and exhibiting!

    This is Step 1. 

    To become a sponsor or exhibitor of 2024 CABS BioPacific Conference, please follow the steps below:

    1. Click the "Sponsor/Register" button at the right-corner and follow the step-by-step process to pay. The price will differ depends on level of sponsorship. Two payment methods:

    A. Pay by credit card.

    B. Pay by check. Click "invoice me" and then print out the invoice in your email. Mail the invoice together with the a check (payable to "CABS") to the following address: 268 Bush Street, #1888, San Francisco, CA 94104. U.S.A.

    2. You will receive an email to confirm your payment. High level sponsors will get free guest conference admission passes. Please go to Step 2 to register yourself and free guests for conference admission. 


    Any question? Please contact: fundraising@cabsweb.org  

    • March 03, 2025
    • 7:30 AM
    • August 18, 2025
    • 6:00 PM
    • Online Zoom Conference
    Register

    Welcome to 2022 BioPacific Conference  and thank you for sponsoring and exhibiting!

    This is Step 1. 

    To become a sponsor or exhibitor of 2022 CABS BioPacific Conference, please follow the steps below:

    1. Click the "Sponsor/Register" button at the right-corner and follow the step-by-step process to pay. The price will differ depends on level of sponsorship. Two payment methods:

    A. Pay by credit card.

    B. Pay by check. Click "invoice me" and then print out the invoice in your email. Mail the invoice together with the a check (payable to "CABS") to the following address: 268 Bush Street, #1888, San Francisco, CA 94104. U.S.A.

    2. You will receive an email to confirm your payment. High level sponsors will get free guest conference admission passes. Please go to Step 3 to register yourself and free guests for conference admission.

    Any question? Please contact: fundraising@cabsweb.org   


    • March 04, 2025
    • May 15, 2025
    • 10


    The Chinese American Biopharmaceutical Society (CABS) is thrilled to announce a new summer internship program focused on the cutting-edge field of data science applied to drug discovery and development.

    As our industry generates unprecedented amounts of data from genomics, proteomics, clinical trials and real-world evidence, there is a growing need for talented data scientists who can derive insights to drive innovation. CABS is committed to helping bridge this talent gap and train the next generation of data leaders in biopharma.

    This 10-week non-paid internship program will provide an immersive experience for undergraduate and graduate students to work alongside data science teams at top CABS member companies in the San Francisco Bay Area. Interns will get hands-on experience applying the latest machine learning, AI and data analytics tools to solve real-world challenges across all phases of the drug development lifecycle.

    Not only will interns gain technical data skills, but they will also learn about the biopharma business through workshops, networking events, and mentorship opportunities with CABS member company leaders, entrepreneurs and investors.

    A primary focus will be nurturing a talented and diverse pipeline of data science professionals, including those from Asian American and Pacific Islander backgrounds. In addition to students from top universities like UC Berkeley, Stanford and UCSF, we strongly encourage applications from students at universities across the Pacific Rim and Asia. 

    Internship Timeline:

    - Applications Open: Feb 15th, 2025

    - Application Deadline: May 15th, 2025

    - Internship Dates: June 15 - August 25, 2025

    This internship program represents an incredible professional development opportunity. We invite all eligible students passionate about life sciences and data to apply!

    For more details on the program, eligibility requirements and how to apply, please contact:

    jessica.sun@cabsweb.org,

    kaymeikuentong@gmail.com or

    shicheng.guo@cabsweb.org

    Please click this link or scan the QR code below

    to finish the online application!

    We look forward to receiving applications from the world's brightest data science minds!

    Sincerely,

    President, CABS

    Feb 02, 2025


    CABS 2025 Mentor Recruitment – Data Science Intern Program

    The Chinese American Biopharmaceutical Society (CABS) is excited to announce our new summer internship program focused on data science in drug discovery and development. As our industry produces vast amounts of data from genomics, proteomics, clinical trials, and real-world evidence, there is a critical need for experienced professionals to mentor the next generation of data science talent in biopharma.

     
    This 10‑week, non‑paid internship program offers undergraduate and graduate students a unique opportunity to work alongside data science teams at CABS member companies in the San Francisco Bay Area. While interns will gain hands-on technical experience with AI, machine learning, and analytics tools, your mentorship will uniquely empower them to navigate real-world challenges and accelerate their career growth.

     
    As a mentor, you will have the opportunity to:
    • Share your expertise and real‑world experience with passionate students.
    • Shape the future of data science and drug development.
    • Enhance your leadership skills by developing and refining your coaching abilities.

    Program timeline:
    • Applications Open: Feb 17, 2025
    • Application Deadline: May 15, 2025
    • Internship Dates: June 15 – August 25, 2025


    Please note: The CABS data science summer internship is fully remote, with no on-site requirements.

    Please click this link or scan the QR code below

    to finish the online application!

    If you’re eager to contribute to the development of future data science leaders and share your knowledge, please complete this application. We look forward to welcoming you as a mentor!


    For any questions, please contact: kay.tong@cabsweb.orgshicheng.guo@cabsweb.org or zuolincheng166@gmail.com




    • March 04, 2025
    • 8:00 AM
    • September 13, 2025
    • 8:00 PM
    • South San Francisco Conference Center

    2025 CABS BioPacific Annual Conference 

    Nomination For K. Fong Award in Life Sciences

    Deadline for nomination: April 30, 2025 

    The CABS K. Fong Award in Life Sciences is presented annually to recognize individuals who have made significant contributions to the life sciences and biopharmaceutical industries. This includes:

    • Outstanding scientific discoveries.

    • Notable efforts in promoting life science education.

    • Initiatives that enhance the life science community.

    • Therapeutic breakthroughs that bring new treatments to market and improve healthcare and quality of life.

    Nomination Process:

    • Candidates must be nominated by an active CABS member.

    • Nominees should have a certain level of involvement in CABS activities previously.

    • Selection will be based on the candidate’s overall accomplishments and contributions to the life science community, including one or more of the following:

      • Proven achievements in therapeutic breakthroughs (e.g., discovery, process, or clinical development), diagnostics, or the research reagent/equipment markets.

      • Significant contributions to the advancement of academic and industrial R&D in biomedical sciences and applications.

      • Notable involvement in the CABS community and efforts in promoting international collaboration in life sciences.

    Winners will be selected by the CABS Award Selection Committee. The recipient(s) will receive a Plaque of Merit at CABS BioPacific Annual Conference on September 13, 2025, at the South San Francisco Convention Center.

    About Dr. Kenneth Fong

    Dr. Kenneth Fong is a renowned entrepreneur, investor, and mentor to many biotech founders. He is a dedicated community leader and philanthropist with significant contributions to higher education and the biotech industry. Currently, Dr. Fong serves as the Chairman of Kenson Ventures, LLC—a venture capital firm specializing in financing and strategic consulting for biotech companies. He is also the founder and former CEO of Clontech, which developed and marketed molecular biology products to academic and pharmaceutical laboratories in the United States and 30 other countries. In addition, he serves on the boards and advisory boards of several biotech organizations in the US, China, Taiwan, and Hong Kong.

    Dr. Fong’s community and philanthropic activities include:

    • Establishing the Fong Optometry and Medical Library at UC Berkeley.

    • Creating the Fong Scholarship Programs and Annual Scientific Symposia at San Francisco State University.

    • Initiating the Annual Fong-Clontech Seminar Series at Indiana University.

    • Serving as Chairman of the San Jose Chinese Performing Arts Center (2000–2002).

    • Supporting the Chinese Historical Society of America (San Francisco, 2000) and pioneering the Biotech Program at the San Jose Tech Museum (1999).

    More recently, Dr. Fong has been actively supporting educational programs for children in under-served and impoverished regions of China. He is a member of Committee 100 and a former board member of the 80-20 Initiative. Currently, Ken dedicates much of his time to cultivating and advising entrepreneurs in the biotech industry, particularly those in the 40–55 age group.


    Past recipients of CABS K. Fong Awards

    2024: Dr. Zach Sweeney, Venture Partner at Versant Ventures, CEO and co- founder of Interline Therapeutics, CSO at Denali Therapeutics

    2023: Dr. Corey Goodman, Managing Partner at venBio, member of National Academy of Sciences, American Academy of Arts and Sciences, and American Philosophical Society, a recipient of Alan T. Waterman Award, Canada Gairdner Biomedical Award, March-of-Dimes Prize, and Gruber Prize in Neuroscience. Co-founder of Exelixis, CEO of Renovis, President at Pfizer.

    2022: Dr. Scott Liu, Founder and CEO, HanchorBio Inc. (Co-Founder and former CEO, Henlius)

    2021: Dr. Xian-Ping Lu, Founder, Chairman and CEO, ChipScreen BioSciences Co.

    Dr. John O. Link, Former VP, Gilead Sciences, Inc (Retired)

    2019: John Oyler, MBA, Founder, CEO and Chairman of BeiGene

    2018: Dr. Guoliang Yu, Executive Chairman, Crown Bioscience, Venture Partner, OrbiMed Venture

    Dr. Yuling Luo, Founder,Chairman and CEO, Alamar Bioscience

    2017: Dr. Yinxiang Wang, Co-founder and CSO of Beta Pharma, for his role in    leading development and commercialization of Conmana®, the first small molecule oncology drug specifically targeting cancer cells that is completely developed in China.

    Dr. Edgar Engleman, for his pioneering research that was the basis of the Sipuleucel-T (Provenge) prostate cancer vaccine, the first active immunotherapy for cancer to be approved by the FDA.

    2016: Dr. Gerald Chen, Co-founder of Morningside, for his extraordinary vision  and leadership in cultivating a generation of successful entrepreneurs and life sciences companies.

    2015: Dr. Irving Weissman, of Stanford University, for his pioneering research in stem cell research.

    2014: Dr. Ge Li, Founder and CEO of Wuxi Apptec, for creating and shaping      the CRO business model in China and Dr. Hing L. Sham, formerly of Abbott for his leading role in the discovery of life- saving HIV protease inhibitors, ritonavir and Iopinavir.

    2013: Dr. Peter Hirth, Plexxikon & Sugen for his pivotal role in advancing 4 successful drugs to the market 

    Dr. Jean Cui, formerly of Pfizer for her role as the lead designer and investigator of crizotinib, a successful kinase inhibiting drug used in personalized medicine.




    • March 07, 2025
    • March 13, 2025

    CABS Hiking Event Invitation

    Dear Friends,

    The call of nature is here! The CABS Social Life Committee (SLC) warmly invites you to an invigorating hiking adventure! Join us on Saturday, March 8, 2025, at Purisima Creek Redwoods Open Space Preserve, San Mateo County. Walk among lush redwood forests, unwind by the babbling creeks, and immerse yourself in the tranquility and grandeur of nature. Whether you are an experienced hiker or simply a nature enthusiast looking for a peaceful escape, we welcome you to be part of this special outdoor experience.

    Additionally, this event presents a fantastic networking opportunity. You’ll have the chance to connect with like-minded professionals, exchange insights, and spark inspiration through engaging conversations while enjoying a refreshing hike.

    Event Details

    Date: Saturday, March 8, 2025
    Meeting Time: 9:30 AM
    Meeting Point: Main Parking Lot, Purisima Creek Redwoods Open Space Preserve

    A map of a trail AI-generated content may be incorrect.

    Purisima Creek Trailhead Parking Lot (North Side)

    • Location: Near Half Moon Bay, on Purisima Creek Road.

    • Parking: Limited space available—carpooling or early arrival is recommended.

       Hiking Route: Purisima Creek Trail (Out & Back)

    • Distance: ~9.5 miles

    • Elevation Gain: ~1,600 feet

    • Difficulty Level: Moderate

    • Scenic Highlights: Towering ancient redwoods, winding creeks, and lush valleys—an immersive nature experience.

    Reminders

    Gear: Wear comfortable, sturdy hiking shoes and dress appropriately for outdoor activities.
    Supplies: Bring enough water and light snacks like nuts or energy bars.
    Punctuality: The hike will begin promptly at 9:30 AM, so please plan your arrival accordingly to avoid missing the group.
    Weather: Check the forecast in advance and prepare for sun protection or warmth as needed.

    About Purisima Creek Redwoods

    A hidden gem of Northern California’s redwood forests, this preserve offers breathtaking scenery, serene woodlands, and the refreshing scent of pine and earth. Whether you're seeking a challenge or a peaceful retreat in nature, this hike promises an unforgettable experience.

    We look forward to hiking with you and sharing the joy of nature and exploration! Feel free to reach out if you have any questions.

    Looking forward to seeing you there!
    CABS SLC Team

    Join our WeChat group if you're interested: 

    A qr code with two people AI-generated content may be incorrect.



    • April 12, 2025
    • 9:30 AM - 1:00 PM
    • 1633 Old Bayshore Hwy #280, Burlingame, CA 94010
    • 112
    Register

    Begin With the End in Mind – Part 1: What Should I Know About Commercialization If I’m Not Planning to Launch a Product Myself?

    In parallel with the scientific roadmap of drug discovery and development, a commercial roadmap also plays a critical role. While commercialization and product launch may seem like separate domains for scientists and startup founders, adopting a commercial mindset early on is essential for success.

    So, what aspects of commercialization should I be aware of?

    • If you are a translational scientist, how does commercialization connect with clinical development? What commercial considerations should you keep in mind when developing a Target Product Profile (TPP)? How do you translate scientific differentiation into clinical differentiation—and ultimately, commercial differentiation?

    • If you are a startup founder, what commercial value should you highlight in your pitch deck? How do you generate key insights, such as market analysis?

    • If you are a biotech executive, how do commercial considerations influence overall company strategy?

    • Or perhaps you are simply interested in exploring a career in the commercial side of biotech and pharma!

    Agenda:

    9:30 - 10:00 AM | Check-in & Networking
    10:00 - 11:00 AM | Fireside Chat: Understanding Key Commercial Concepts – What Do These Terms Really Mean?
    11:00 - 12:00 PM | Panel Discussion: Commercial positioning, Market Research, Forecasting, Marketing, Market Access, Medical Affairs, and Pricing
    12:00 - 1:00 PM | Lunch & Networking

    Speaker:

    Alvin Lin, MBA

    Alvin (Al) Lin is Vice President of Commercial Strategy at Vera Therapeutics. His experience includes lifecycle leader, new product planning, portfolio management, BD valuations, market access, marketing, field sales, and commercial operations. He has commercialized medicines including IMBRUVICA (ibrutinib) and SOLIRIS (eculizumab) and has launched multiple products into US and exUS markets.  He has worked in the past at Merck, Pharmacyclics, and Alexion, and has degrees from Cornell, MIT, and the Tufts School of Medicine.


    Connie Tat, Ph.D.

    Senior Medical Science Director, Oncology

    Genentech  

    Connie is a strategic biopharmaceutical operator with nearly a decade of diverse experiences across discovery, development and commercialization at globally successful companies. At Genentech, she set the strategic direction of the GU oncology portfolio and advanced the execution of clinical trials (including research collaborations) towards commercialization within the U.S. healthcare ecosystem. Previously, she led regional cross functional teams on the launch of LUMAKRAS at Amgen and worked in competitive intelligence at Exelixis. Prior to Exelixis, Connie worked in biotech equity research at SunTrust Robinson Humphrey in NYC and consulted at Kantar Health focused on early to late stage biotech/biopharma.

    Connie trained as a scientist and earned her Ph.D. in Microbiology and Immunology at UC Irvine and Bachelors of Arts in Molecular and Cellular Biology at UC Berkeley. She is passionate about translating innovative scientific discoveries into commercial products that impact patient lives.


    Jennifer Shen, MD, MS

    Jennifer Shen is a physician scientist with extensive experience in both buy-side and sell-side business development. She also previously worked as a corporate venture investor at AstraZeneca, where she contributed to two Series A investments and spin-out deals, managed a $2 billion equity portfolio across 30 public companies, and served as a board observer for two stealth clinical stage biotech companies. Prior to AZ, Jennifer also held a role as a biotech equity researcher at the investment bank Needham and Co, responsible for IPOs of Moderna, Vaxcyte, and Pathom.

    Jennifer held a decade-long career as a medical professional and scientific researcher where earned an M.S. and completed a postdoctoral research fellowship at Stanford, followed by an M.D. from SUNY Buffalo. She also worked as a general surgery intern at USC and anesthesia resident at New York Medical College.


    For questions, please email: lu.lu@cabsweb.org 


    • September 13, 2025
    • 8:00 AM
    • March 09, 2026
    • 6:00 PM
    • South San Francisco Convention Center
    Register

    Welcome to 2025 BioPacific Conference  and thank you for sponsoring and exhibiting!

    This is Step 1. 

    To become a sponsor or exhibitor of 2025 CABS BioPacific Conference, please follow the steps below:

    1. Click the "Sponsor/Register" button at the right-corner and follow the step-by-step process to pay. The price will differ depends on level of sponsorship. Two payment methods:

    A. Pay by credit card.

    B. Pay by check. Click "invoice me" and then print out the invoice in your email. Mail the invoice together with the a check (payable to "CABS") to the following address: 268 Bush Street, #1888, San Francisco, CA 94104. U.S.A.

    2. You will receive an email to confirm your payment. High level sponsors will get free guest conference admission passes. Please go to Step 2 to register yourself and free guests for conference admission. 


    Any question? Please contact: fundraising@cabsweb.org  

Powered by Wild Apricot Membership Software